Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Flotillin-2 is a membrane-associated scaffolding protein of the SPFH superfamily, functioning as a principal component of lipid raft microdomains. It is ubiquitously expressed in mammalian cells and plays a critical role in organizing multiprotein complexes at the plasma membrane and endomembranes. Flotillin-2, often together with flotillin-1, facilitates clathrin-independent endocytosis, cell signaling, and protein trafficking by forming large oligomeric complexes—sometimes described as basket- or cage-like structures—that isolate and coordinate localized biochemical processes. Its membrane attachment is regulated through *N*-myristoylation and *S*-palmitoylation, contributing to its association with cholesterol- and sphingolipid-rich raft domains. Flotillin-2 is implicated in cancer progression, neurodegenerative diseases, and possibly immunological and infectious pathologies, largely owing to its role in membrane dynamics, signaling, and vesicular transport.
Not directly targeted pharmacologically; proposed mechanisms involve disruption of flotillin-2 oligomerization or membrane association to block its scaffolding function (hypothetical, preclinical context).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Flotillin-2 (FLOT2).